Cargando…
Management of patients with Clozapine Resistant Schizophrenia
BACKGROUND -: About 20-30% of patients with schizophrenia have treatment resistant schizophrenia (TRS). Clozapine is the only FDA approved drug to be used in patients with TRS. However, only 40-70% people with TRS show clinical response on clozapine, the rest being termed as Clozapine resistant schi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129788/ http://dx.doi.org/10.4103/0019-5545.341696 |